Insulin Like Growth Factor Binding Protein 7 as a Novel Diagnostic Marker in Sera of Iraqi Patients with Acromegaly

Main Article Content

Layla Othman Farhan
Baydaa Ahmed Abed
Kashtl Ghasaq J.
https://orcid.org/0000-0003-0883-1143
Isam Noori Salman

Abstract

The purpose of this study was to measure serum levels of insulin-like growth factor-binding protein (IGFBP7), Insulin-like Growth Factor 1 (IGF-1), Growth Hormone (GH), Interleukin 6 (IL-6) and insulin in acromegaly patients and healthy controls. The acromegaly group had 60 patients, while the population group had 30 people who had never had acromegaly before. The concentration of IGFBP7, IGF-1, GH, IL-6, and insulin were determined. The results of the present study indicate that IGFBP7 level in the acromegaly group was significantly lower (1.690.07 ng/mL vs. 2.740.12 ng/mL, respectively, p = 0.001). IGF-1, GH, IL-6, and insulin concentrations were also significantly higher in acromegaly patients. The diagnostic accuracy (2.194) was excellent in separating acromegaly from the healthy patient group, and the area under the curve (AUC = 0.871, p = 0.001). From the results of the present study, we can conclude that serum IGFBP7 can be used to distinguish acromegaly patients from healthy individuals.

Article Details

How to Cite
1.
Insulin Like Growth Factor Binding Protein 7 as a Novel Diagnostic Marker in Sera of Iraqi Patients with Acromegaly. Baghdad Sci.J [Internet]. 2023 Jun. 20 [cited 2024 Dec. 19];20(3(Suppl.):0979. Available from: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/7797
Section
article

How to Cite

1.
Insulin Like Growth Factor Binding Protein 7 as a Novel Diagnostic Marker in Sera of Iraqi Patients with Acromegaly. Baghdad Sci.J [Internet]. 2023 Jun. 20 [cited 2024 Dec. 19];20(3(Suppl.):0979. Available from: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/7797

References

Lawrence L, Alkwatli K, Bena J, Prayson R, Kshettry V, Recinos P, et al. Acromegaly: a clinical perspective. Clin. Diabetes Endocrinol. 2020; 6(1): 1–9. https://doi.org/10.1186/s40842-020-00104-5

Wolters TLC, Netea MG, Riksen NP, Hermus ARMM, Netea-Maier RT. Acromegaly, inflammation and cardiovascular disease: Rev Endocr Metab Disord 2020; 21: 547–68. https://doi.org/10.1007/s11154-020-09560-x

Brue T, Lindberg A, Jan van der Lely A, Akerblad AC, Koltowska-Häggström M, Gomez R, et al. Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy. Endocr. J.2019; 63(3): 563–72. https://doi.org/10.1007/s12020-018-1792-0.

Jin L, Shen F, Weinfeld M, Sergi C. Insulin growth factor binding protein 7 (IGFBP7)-related cancer and IGFBP3 and IGFBP7 crosstalk. Front Oncol. 2020; 10: 727. https://doi.org/10.3389/fonc.2020.00727

Sharker MR, Hossen S, Nou I-S, Kho KH. Characterization of insulin-like growth factor binding protein 7 (igfbp7) and its potential involvement in shell formation and metamorphosis of Pacific abalone, Haliotis discus hannai. Int J Mol Sci. 2020; 21(18):6529. https://doi.org/10.3390/ijms21186529

Wang S, Chi K, Wu D, Hong Q. Insulin-like growth factor binding proteins in kidney disease. Front Pharmacol.2021;22(12):807119. https://doi.org/10.3389/fphar.2021.807119.

Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev. 1997; 18(6): 801–31. https://doi.org/10.1210/edrv.18.6.0321

Farhan LO, Taha EM, Farhan AM. A Case control study to determine Macrophage migration inhibitor, and N-telopeptides of type I bone collagen Levels in the sera of osteoporosis patients. Baghdad Sci J. 2022;19(4):848. https://doi.org/10.21123/bsj.2022.19.4.0848

Bolomsky A, Hose D, Schreder M, Seckinger A, Lipp S, Klein B, et al. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma. J Hematol Oncol. 2015; 8(1): 1–14. https://doi.org/10.1186/s13045-014-0105-1

Khaleel FM, N-Oda N, A Abed B. Disturbance of Arginase Activity and Nitric Oxide Levels in Iraqi Type 2 Diabetes Mellitus. Baghdad Sci J. 2018; 15(2):18991. https://doi.org/https://doi.org/10.21123/bsj.2018.15.2.0189

Qiu B, Chu L-Y, Li X-X, Peng Y-H, Xu Y-W, Xie J-J, et al. Diagnostic Value of Serum Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Colorectal Cancer. Onco Targets Ther. 2020; 13: 12131. https://doi.org/10.7717/peerj.15419

Zafar M, Irum S, Khan L, Sadia H, Roshan S, Rahman TU, et al. Prevalence of Diabetes Mellitus in Hepatitis C Patients in Wazirabad Tehsil of Gujranwala District of Pakistan: hepatitis C in Diabetic patients. Baghdad Sci J. 2020; 17(4): 1154. https://doi.org/10.21123/bsj.2020.17.4.1154

Kashtl GJ, Abed BA, Farhan LO, Noori I, Salman ASD. A Comparative Study to Determine LDH Enzyme Levels in Serum Samples of Women with Breast Cancer and Women with Breast Cancer and Type 2 Diabetes Mellitus. J. Med. Chem. Sci. 2023; 6(4):883-890. https//doi.org/10.26655/JMCHMSCL.2023.4.20

Lisowska A, Szyszkowska A, Knapp M, Łapińska M, Kondraciuk M, Kamińska I, et al. IGFBP7 Concentration May Reflect Subclinical Myocardial Damage and Kidney Function in Patients with Stable Ischemic Heart Disease. Biomolecules. 2022; 12(2): 274. https://doi.org/10.3390/biom12020274

Akiel M, Guo C, Li X, Rajasekaran D, Mendoza RG, Robertson CL, et al. IGFBP7 Deletion Promotes Hepatocellular CarcinomaPromotion of HCC in Igfbp7ko Mice. Cancer Res. 2017; 77(15): 4014–25. https://doi.org/10.1158/0008-5472.CAN-16-2885.

Akiel M, Guo C, Li X, Rajasekaran D, Mendoza RG, Robertson CL, et al. IGFBP7 deletion promotes hepatocellular carcinoma. Cancer Res. 2017; 77(15): 4014–25. https://doi.org/10.1158/0008-5472.CAN-16-2885

Szyszkowska A, Knapp M, Kaminski K, Lisowska A. Insulin-like growth factor-binding protein 7 (IGFBP7): Novel, independent marker of cardiometabolic diseases? Postepy Hig Med Dosw. 2019; 73: 735–40. https://doi.org/10.3390/biom12050712

Kim S-Y, Kim M, Oh Y, Lee D-Y. Relationship of Serum Total Insulin-Like Growth Factor Binding Protein-3 with Insulin-Like Growth Factor-I and Glucose Tolerance in Korean Children and Adolescents. Int J Endocrinol. 2021; 1(22): 9966114. https://doi.org/10.1155/2021/9966114

Haywood NJ, Slater TA, Matthews CJ, Wheatcroft SB. The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes. Mol Metab. 2019; 19: 86–96. https://doi.org/10.1016/j.molmet.2018.10.008

Farhan LO, Farhan AM, Al Obaidi S, Taha EM. A Case-control Study to Determine Metalloproteinase-12 and Lysyl Oxidase Levels in Iraqi women with Osteoporosis.RJPT.2022;15(6):41–7. https://doi.org/10.5271/0974-360X.2022.00444

Hasan BF, Salman IN, Hamzah NA. The Relation of IGF-1 and Insulin Resistance in a Sample of Iraqi Obese Type 2 Diabetic Patients with Macrovascular. Baghdad Sci J. 2012 ;9(4):1-9. https://doi.org/10.21123/bsj.2012.9.4.656-662

Similar Articles

You may also start an advanced similarity search for this article.